Developing the analytics and analytical workflows supporting the analysis of the next generation of biotherapeutic and gene therapies

[ APPLICATION NOTE ] Optimizing Adeno-Associated Virus (AAV) Capsid Protein Analysis Using UPLC and UPLC-MS Ximo Zhang, Stephan Koza, Ying Qing Yu, and Weibin Chen Waters Corporation, Milford, MA, USA APPLICATION BENEFITS ■ ■ INTRODUCTION An optimized LC-MS solution for…

Nové léčebné terapie a jejich analytika Jak pandemie urychlila vývoj genových terapií Martin Gilar 23. 11. 2021, Vize 2021 Příslib genových terapií ▪ Známe generický kód - můžeme léčit jakoukoliv nemoc ▪ Obecný mechanismus - specifický DNA cíl ▪ Nejen…

Analytical solutions to accelerate your AAV gene therapy Gene therapy holds great promise for a wide range of diseases, including cancers, cardiovascular diseases and thousands of rare hereditary diseases caused by gene mutations. HE ALTHY GENE VIR AL VECTOR WITH…

Advanced Therapeutic Medicinal Products: Adeno-associated Virus (AAV) The Promise of Viral Vector Gene Therapy using AAV 7000 Monogenic Diseases 20 of 22 4 Years Children with spinal muscular atrophy (SMA) given the ability to thrive with Zolgensma® (AAV) at 91%…